Navigation Links
Alexza Pharmaceuticals Announces Upcoming Webcasts and Conference Participation
Date:8/27/2008

MOUNTAIN VIEW, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today the company's participation and that Thomas B. King, Alexza President and CEO, will present at the following investor conferences in September.

Conference: NewsMakers in the Biotech Industry

Location: Millennium Broadway Hotel & Conference Center

145 West 44th Street, New York

Presentation Date: Thursday, September 4, 2008

Presentation Time: 10:30 a.m. ET

Conference: UBS Global Life Sciences Conference

Location: Grand Hyatt Hotel

109 East 42nd Street, New York

Presentation Date: Monday, September 22, 2008

Presentation Time: 4:00 p.m. ET

A live webcast of each presentation will be available, and can be accessed via the Investor Relations section of the Alexza website, at http://www.alexza.com. A replay of the webcast will be made available approximately 24 hours after the live presentation and the replay will be archived for 14 days.

About Alexza Pharmaceuticals

Alexza Pharmaceuticals is an emerging specialty pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato(R) system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient com
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Alexza to Announce 2008 Second Quarter Financial Results and Update Its Clinical Pipeline on Wednesday, August 6, 2008
2. Christopher Kurtz Joins Alexza Pharmaceuticals as Vice President, Global Supply Chain and Sustainment Engineering
3. Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates
4. Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore
5. Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008
6. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
7. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
8. Alexzas Corporate Presentation to be Webcast at the 10th Annual BIO CEO & Investor Conference
9. Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation
10. Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America
11. Alexza Elects Dr. Hal V. Barron to Its Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...iding smart and efficient software to the preclini...olutionizing work-from-home histopathology by util...e used by 8 of the Top 10 Pharmaceutical Companies...o; basis. , Mount Arlingt...ced another evolution in the histopathology realm ...
(Date:11/30/2009)...DAM, November 30 Elsevie...dical and technical products and services,today a...nsive biomedical,database which holds over 20 mill...eer reviewed journals. , Embase has long ...ical,and pharmaceutical insights. Now, new develop...
(Date:11/27/2009)...e test alternative is helping bring complete auto...ser for pharma-companies. It is a non-destructive,...Sepha for use with blister packs and it has alrea...ma-companies such as Sanofi-Avenis and Zydus-Cadil...mprovements on the packaging line. Blisterscan ...
(Date:11/25/2009)...N, Fla., Nov. 25 For many business...ogicMD. The nation,s largest and fastest growing ...ely in medically supervised bioidentical hormones...twork since November 2008 - from 21 to 36 physi...owned centers, including one in Puerto Rico, by th...
Breaking Biology Technology:Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4
... Feb. 25 The International,Confocal Microscopy Wo...ssionals and students, has been formed as a means ...lective confocal microscopy (RCM) in,patient care....bers worldwide.,Dermatologists, dermascopists, der...ssionals interested in learning more about RCM sho...
...25 Barr Pharmaceuticals,Inc. (NYSE: BRL ) today ...cals, Inc., has received notification that the U.S...for review its New Drug Application,(NDA) for Lo S...lets 0.10,mg/0.02 mg and ethinyl estradiol tablets...ompany is seeking approval to manufacture and mark...
.... 25 Nile Therapeutics,Inc. (OTC Bulletin Board: ...eveloping therapies for cardiovascular disease, is...Lieu, M.D., F.A.C.C. as its Vice President of,Clin...eu to Nile. Dr. Lieu has extensive,cardiovascular ...mmediately,beneficial to Nile and our CD-NP and 2N...
Other Biology Technology:International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy 2Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 2Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 3Duramed's Lo SEASONIQUE(R) NDA Accepted for Filing by FDA 4Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 2Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics 3
(Date:11/26/2009)... MRSA (methicillin-resistant Staphylococcus Aure...annihilation as low-temperature plasma prototype d...asy and unfailing bactericidal cocktails. , Two ...icient disinfection of healthy skin (e.g. hands an...ria can pose a lethal threat; and another to shoot...
(Date:11/25/2009)... Athens, Ga. Bacteria don,t have easy lives. In ...the bugs, they have natural enemies called bacteri...rth every two days. , Still, bacteria and anoth...iscovered in extreme environments such as deep-sea...art because they have a built-in defense system th...
(Date:11/25/2009)... MADISON, WI, NOVEMBER 25, 2009 Soil is the linc...re, and hydrosphere meet. Despite that, many stude...s, but nothing more. Soil science educators are ch... public recognize the critical importance of soil ...y soil science and earth science teachers at Unive...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3It's not just dirt! 2Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009 13954 1Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009 13954 2Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 1Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 2Scientists Find Clue to Dangerous Side Effect of MS Drug 56673 3Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 1Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 2Kmart Pharmacy Flu Clinics Begin September 10 2009 56669 3
...c? If you,re a health care professional you,d bett...n estimated 1.3 million people in the United State...rs, and the U.S. Federal Drug Administration (FDA)...hese errors, such as a documented case in which a ... Norcuron and went into cardiac arrest. , A few ...
...evelopment, Dr. Mary Ellen Perry and colleagues va...get for cancer therapies. , The p53 tumor suppress...many anticancer strategies aim to activate p53 in ...itor of p53 and therefore an attractive target to ...ng evidence exists regarding whether or not p53-me...
... death by suicide generally decreases in the weeks...tion, according to a new study led by Group Health...ary issue of The American Journal of Psychiatry. T...vior after starting 10 newer antidepressant medica...ions. , These findings challenge a 2004 advisory ...
Other Biology News:Computer scientist sorts out confusable drug names 2Suicide risk does not increase when adults start using antidepressants, study finds 2
Anti-G Protein Gq / 11a Subunit, Internal Sequence, a.a. 115-133 Polyclonal Antibody, Unconjugated from CHEMICON
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Calf Liver tRNA from Novagen
Biology Products: